Upgrade to SI Premium - Free Trial

Precision BioSciences (DTIL)

6.83 +0.12 (1.79%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026 October 8, 2026 7:01 AM - BizWire Form 4 PRECISION BIOSCIENCES For: Sep 28 Filed by: Frankel Stanley September 30, 2026 4:15 PM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Sep 25 Filed by: Brown Melinda September 29, 2026 7:00 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Sep 25 Filed by: Germano Geno J September 29, 2026 7:00 AM - SEC Filing iECURE Presents Updated Clinical Data from OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM 2026 August 27, 2026 8:00 AM - BizWire Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: Weinstein Benjamin August 24, 2026 3:13 PM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: Aug 24 August 24, 2026 7:01 AM - SEC Filing Precision BioSciences doses first patient in DMD gene-editing trial August 24, 2026 6:01 AM - StreetInsider Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study August 24, 2026 6:01 AM - BizWire iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium August 20, 2026 8:00 AM - BizWire Form S-8 PRECISION BIOSCIENCES August 7, 2026 8:35 AM - SEC Filing Form 10-Q PRECISION BIOSCIENCES For: Jun 30 August 6, 2026 7:17 AM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: Aug 06 August 6, 2026 7:16 AM - SEC Filing Precision BioSciences (DTIL) Misses Q2 EPS by 50c August 6, 2026 7:07 AM - StreetInsider Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update August 6, 2026 7:01 AM - BizWire Form 3 PRECISION BIOSCIENCES For: Aug 01 Filed by: Gorsuch Cassandra Louise August 3, 2026 7:17 AM - SEC Filing Form 3 PRECISION BIOSCIENCES For: Aug 01 Filed by: Burris Mei Zhang Lu August 3, 2026 7:17 AM - SEC Filing Form 3 PRECISION BIOSCIENCES For: Aug 01 Filed by: Tanna Naresh Haresh August 3, 2026 7:17 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Precision BioSciences Inc. (DTIL) August 3, 2026 6:57 AM - StreetInsider Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026 July 31, 2026 7:01 AM - BizWire Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: Empery Asset Management, LP July 29, 2026 4:16 PM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: Jul 23 July 27, 2026 7:31 AM - SEC Filing Precision BioSciences shifts CFO and creates COO role July 27, 2026 7:02 AM - StreetInsider Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones July 27, 2026 7:01 AM - BizWire Full Article List